共 24 条
Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms
被引:22
作者:
Lepelletier, Didier
[1
,2
]
Cady, Anne
[1
]
Caroff, Nathalie
[1
,2
]
Marraillac, Julie
[1
]
Reynaud, Alain
[1
,2
]
Lucet, Jean-Christophe
[3
]
Corvec, Stephane
[1
,2
]
机构:
[1] Nantes Univ Hosp, Dept Bacteriol Hyg, Nantes, France
[2] Univ Nantes, UFR Med, Therapeut Clin & Expt Infect EA3826, F-44035 Nantes, France
[3] Grp Hosp Bichat Claude Bernard, Infect Control Dept, Paris, France
关键词:
Imipenem resistance;
Pseudomonas aeruginosa;
case-control study;
gastrointestinal carriage;
INTENSIVE-CARE UNITS;
ANTIBIOTIC-RESISTANCE;
COLONIZATION;
INFECTION;
OPRD;
ENDEMICITY;
EMERGENCE;
D O I:
10.1016/j.diagmicrobio.2009.08.014
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
Risk factors for imipenem (IMP)-resistant Pseudomonas aeruginosa (IRPA) digestive carriage were analyzed, and genetic events contributing to select resistant isolates in patients exposed to IMP were investigated. Among the 150 patients with hospital-acquired P. aeruginosa digestive carriage, 38 isolates were IRPA. DNA pulsotypes revealed 16 distinct clones. In 4 patients, a second P. aeruginosa isolate showed resistance to IMP compared with the initial susceptible isolate. By comparing the different oprD sequences between IMP-susceptible P. aeruginosa and IRPA strains, a genetic event was systematically found for each resistant isolate, leading to either the absence of OprD or a truncated porin. The multivariate analysis demonstrated that prior IMP exposure was associated with IRPA carriage. In summary, we confirmed that IMP use selects for IRPA in the gut flora. Cross-transmission, however, was frequently observed in intensive care units. Combining epidemiologic approach and molecular analysis is a powerful tool to delineate mechanisms of emerging resistance. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文